Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytori Therapeutics Inc (NASDAQ:CYTX)

2.03
Delayed Data
As of Sep 30
 +0.02 / +1.00%
Today’s Change
1.81
Today|||52-Week Range
6.45
-26.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues8.7M7.1M5.0M4.8M
 
 
 
 
 
Cost of Goods Sold3.1M1.8M2.2M2.1M
 
 
 
 
 
Depreciation And Amortization933.0K1.6M779.0K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income4.7M3.7M2.0M1.7M
 
 
 
 
 
General Expenses38.8M42.1M37.5M31.4M
 
 
 
 
 
Research And Development13.6M17.1M15.1M19.0M
 
 
 
 
 
Total Operating Expenses42.8M45.5M40.4M34.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.1M-38.4M-35.5M-29.8M
 
 
 
 
 
Extraordinary Credit0.008.2M369.0K7.7M
 
 
 
 
Extraordinary Charge-131.0K-708.0K0.00-260.0K
 
 
 
 
Pre-Tax Equity Earnings-165.0K-48.0K0.000.00
 
 
 
Interest Expense On Debt3.4M4.0M4.4M3.4M
 
 
 
 
 
Other Expenses5.5M8.8M2.1M7.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.3M-26.2M-37.4M-18.7M
 
 
 
 
 
Net Income-32.3M-26.2M-38.5M-19.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.9M4.5M5.4M9.4M
 
 
 
 
 
Shares To Calculate EPS Diluted3.9M4.5M5.4M9.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.25-$5.85-$7.20-$2.10
 
 
 
 
 
EPS Diluted-$8.25-$5.85-$7.20-$2.10